You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
14 March 2024
Epigenomics AG publishes financial results for fiscal year 2023
12 March 2024
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
6 March 2024
15 February 2024
Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
31 January 2024
Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board
26 January 2024
Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD)
18 January 2024
30 November 2023
Veröffentlichung gemäß § 50 WpHG mit dem Ziel der europaweiten Verbreitung
22 November 2023
30 October 2023
Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
27 October 2023
18 October 2023
10 October 2023
Epigenomics AG Announces Closing of Agreement on the Acquisition of Almost All of the Company’s Assets and Adjustment of Guidance for 2023
Epigenomics AG: Closing of Agreement on the Acquisition of Almost All Assets and Adjustment of Guidance for 2023
11 September 2023
Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company
5 September 2023
Epigenomics AG: Pareto and Warburg publish analyst research reports
10 August 2023
Epigenomics AG publishes financial results for the first six months 2023
8 August 2023
2 August 2023
Epigenomics AG: Capital reduction planned at a ratio of 5 : 1
24 July 2023
Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets
Epigenomics AG: Agreement on the Acquisition of Almost All Assets
12 June 2023
Epigenomics AG: Negotiations on the Acquisitions of Almost All Assets
31 May 2023
Epigenomics AG Reports Financial Results for the First Quarter of 2023
19 May 2023
Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
Epigenomics AG: Changes in the Management
28 April 2023
Epigenomics AG publishes financial results for fiscal year 2022
26 April 2023
12 April 2023
Epigenomics AG: Chief Executive Officer Greg Hamilton Resigns
29
May 24
Annual General Meeting
30
Sep 24
Publication half-yearly financial report